Trade Trends of wuhan biocause pharmaceutical development co ltd

from Jan 2022 to Sept 2025
Shipments Imported: 0
As Buyer Trade Value (USD): $0
Shipments Exported: 11
As Supplier Trade Value (USD): $90.13 K

Import and Export shipments of "wuhan biocause pharmaceutical development co ltd"

As Supplier
Consignee NameShipper NameHS CodeShipment Weight (kg)Product KeywordsShipment Date
2933790.12
Milrinone - raw material for the production of Itamerinon 10 injection, SDK: 893110037824. Manufacturer: Wuhan Biocause Pharmaceutical Development Co., Ltd. Batch number: 312-230403 Manufacturer: April 23, 2023, Expiry date: April 22, 2026. 100% new
Mar 13, 2025
cong ty tnhh san xuat duoc pham medlac pharma italy
wuhan biocause pharmaceutical development co ltd
2933790.12
Milrinone - raw material for the production of Itamerinon 10 injection, SDK: 893110037824. Manufacturer: Wuhan Biocause Pharmaceutical Development Co., Ltd. Batch number: 312-230403 Manufacturer: April 23, 2023, Expiry date: April 22, 2026. 100% new
Mar 13, 2025
cong ty tnhh san xuat duoc pham medlac pharma italy
wuhan biocause pharmaceutical development co ltd
2933790.12
Milrinone - raw material for the production of Itamerinon 10 injection, SDK: 893110037824. Manufacturer: Wuhan Biocause Pharmaceutical Development Co., Ltd. Batch number: 312-230403 Manufacturer: April 23, 2023, Expiry date: April 22, 2026. 100% new
Mar 13, 2025
cong ty tnhh san xuat duoc pham medlac pharma italy
wuhan biocause pharmaceutical development co ltd
2933790.12
Milrinone - raw material for the production of Itamerinon 10 injection, SDK: 893110037824. Manufacturer: Wuhan Biocause Pharmaceutical Development Co., Ltd. Batch number: 312-230403 Manufacturer: April 23, 2023, Expiry date: April 22, 2026. 100% new
Mar 13, 2025
cong ty tnhh san xuat duoc pham medlac pharma italy
wuhan biocause pharmaceutical development co ltd
2933790.12
Milrinone - raw material for the production of Itamerinon 10 injection, SDK: 893110037824. Manufacturer: Wuhan Biocause Pharmaceutical Development Co., Ltd. Batch number: 312-230403 Manufacturer: April 23, 2023, Expiry date: April 22, 2026. 100% new
Mar 13, 2025
Premium Content Locked

Trademo turns 3B+ shipment records and 15M+ company profiles into actionable data for trade prospecting. Subscribe to Trademo Intel to grow the pipeline.

Trading Partners of wuhan biocause pharmaceutical development co ltd

Top Companies "wuhan biocause pharmaceutical development co ltd" is exporting to (by Value USD)

Buyer2025202420232022
vinphaco
-15.52 K12.63 K11.4 K
hera biopharm co ltd
-32.49 K--
lock_icon
4.96 K4.9 K--
lock_icon
--3.36 K3.32 K
lock_icon
--1.03 K-

Markets in which wuhan biocause pharmaceutical development co ltd trades

Top Countries "wuhan biocause pharmaceutical development co ltd" is exporting to (by Value USD)

Importing Country2025202420232022
country flagsvietnam
4.96 K52.9 K12.63 K11.4 K
country flagsrussia
--3.36 K3.32 K
country flagspakistan
---528.67

Top Port Pairs of "wuhan biocause pharmaceutical development co ltd" as Supplier (by Value USD)

Port Pairs2022
beijing
 -> 
hanoi
2.48 K

Products/HS Codes traded by wuhan biocause pharmaceutical development co ltd

Top HS Codes Exported by "wuhan biocause pharmaceutical development co ltd"

USD 39.55 K | 36.36%

Organic chemicals Heterocyclic compounds with nitrogen hetero-atom(s) only. -- Other

USD 10.89 K | 27.27%

Organic chemicals Heterocyclic compounds with nitrogen hetero-atom(s) only. -- Other lactams

USD 6.68 K | 18.18%

Organic chemicals Diazo-, azo- or azoxy-compounds. Diazo-, azo- or azoxy-compounds.

USD 32.49 K | 9.09%

Organic chemicals Heterocyclic compounds with nitrogen hetero-atom(s) only. -- Other

USD 528.67 | 9.09%

Organic chemicals Alkaloids, natural or reproduced by synthesis, and their salts, ethers, esters and other derivatives. - Other

Intel
Identify in-market buyers, prioritize high-potential accounts, and accelerate pipeline growth.
Subscribe to Intel Now→

Similar Companies to wuhan biocause pharmaceutical development co ltd

Other Buyers and Suppliers in china who deal in similar products like wuhan biocause pharmaceutical development co ltd